Insulet (PODD) Net Cash Flow (2010 - 2026)
Insulet (PODD) posted Net Cash Flow of -$233.8 million for Q1 2026, down 456.67% on a QoQ basis from -$42.0 million in Q4 2025, and down 171.74% year-over-year from $325.9 million in Q1 2025.
Insulet (PODD) Net Cash Flow (2010 - 2026) Analysis & Trends
Insulet's Net Cash Flow history runs 17 years deep, the most recent figure standing at -$233.8 million for Q1 2026.
- Quarterly Net Cash Flow fell 171.74% year-over-year to -$233.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$808.4 million (down 251.84% YoY) and the FY2025 annual result came in at -$248.7 million, down 197.15% from the prior year.
- Net Cash Flow was -$233.8 million for Q1 2026 at Insulet, down from -$42.0 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $325.9 million in Q1 2025 and bottomed at -$362.3 million in Q3 2025.
- A 5-year average of -$19.2 million and a median of $15.8 million in 2023 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2023 — Net Cash Flow surged 1238.89% — and 2025, when it tumbled 569.91%.
- Insulet's Net Cash Flow stood at -$52.2 million in 2022, then soared by 130.27% to $15.8 million in 2023, then jumped by 271.52% to $58.7 million in 2024, then sank by 171.55% to -$42.0 million in 2025, then tumbled by 456.67% to -$233.8 million in 2026.
- Business Quant data shows PODD's Net Cash Flow at -$233.8 million in Q1 2026, -$42.0 million in Q4 2025, and -$362.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.52 Bn | 175.22 Bn | 6.27 Bn | -1.70 Bn |
| 2 | Stryker | 128.96 Bn | 126.09 Bn | 3.81 Bn | -1.11 Bn |
| 3 | Medtronic | 107.99 Bn | 98.77 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 67.76 Bn | 66.31 Bn | 3.61 Bn | -503.00 Mn |
| 5 | Edwards Lifesciences | 48.09 Bn | 44.41 Bn | 1.29 Bn | -500.20 Mn |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn | 202.10 Mn |
| 7 | GE HealthCare Technologies | 27.89 Bn | 25.61 Bn | 1.98 Bn | -2.19 Bn |
| 8 | Smith & Nephew | 27.02 Bn | 26.45 Bn | - | - |
| 9 | Koninklijke Philips | 23.98 Bn | 20.86 Bn | 2.07 Bn | -282.15 Mn |
| 10 | Insulet | 11.56 Bn | 11.07 Bn | 529.10 Mn | -233.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -233.80 Mn |
| Mar 31, 2026 | -233.80 Mn |
| Dec 31, 2025 | -42.00 Mn |
| Dec 31, 2025 | -42.00 Mn |
| Sep 30, 2025 | -362.30 Mn |
| Sep 30, 2025 | -362.30 Mn |
| Jun 30, 2025 | -170.30 Mn |
| Jun 30, 2025 | -170.30 Mn |
| Mar 31, 2025 | 325.90 Mn |
| Mar 31, 2025 | 325.90 Mn |
| Dec 31, 2024 | 58.70 Mn |
| Dec 31, 2024 | 58.70 Mn |
| Sep 30, 2024 | 77.10 Mn |
| Sep 30, 2024 | 77.10 Mn |
| Jun 30, 2024 | 70.70 Mn |
| Jun 30, 2024 | 70.70 Mn |
| Mar 31, 2024 | 49.50 Mn |
| Mar 31, 2024 | 49.50 Mn |
| Dec 31, 2023 | 15.80 Mn |
| Dec 31, 2023 | 15.80 Mn |